Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - STOCK-BASED COMPENSATION
Stock-based Compensation ANAB - AnaptysBio, Inc.
33.2 M
LAST VALUE
47.09%
2 YEAR CAGR
27.23%
5 YEAR CAGR
71.48%
10 YEAR CAGR